Show 1179: What Should You Do About Digestive Distress? (Archive)

The People's Pharmacy

Joe and Terry Graedon

Medicine, Health & Fitness, Alternative Health, Kids & Family

4.5 • 934 Ratings

🗓️ 1 April 2021

⏱️ 59 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Have you ever had horrible heartburn or a really bad bellyache? Most of us have experienced digestive distress at one time or another. When do you need to seek medical attention for your problem? What Causes Digestive Distress? When the gastrointestinal tract is working as it should, you chew your food and swallow it. Then […]

Transcript

Click on a timestamp to play from that location

0:00.0	I'm Joe Gradyton and I'm Terry Grady welcome to this podcast of the People's Pharmacy.
0:06.1	You can find previous podcasts and more information on a range of health topics at people's Pharmacy.com.
0:14.0	If you have indigestion, what do you do?
0:17.0	Reach for Peps or Tums.
0:19.0	When should you see the doctor?
0:21.0	This is the People's Pharmacy with Terry and Joe Grayden. A bad belly ache can really get your attention. When should you seek medical attention?
0:40.0	Everybody over 50 needs to be screened for colon cancer.
0:43.3	What's the best method, colonoscopy, or something else like Kola Guard?
0:48.4	What are the pros and cons?
0:51.1	Which digestive tract symptoms are alarming and which can you manage at home.
0:56.2	What are the most common problems and which ones are most serious?
1:00.7	Find out what to do.
1:02.1	Coming up on the People's Pharmacy, your calls and questions about digestive tract distress. In the People's Pharmacy Health Headlines, scientists have been concerned that evolving
1:20.1	variants of the SARS COV2 virus might not provoke an immune response in people who have
1:26.6	recovered from COVID.
1:28.8	Two new studies indicate, however, that so far immune response from antibodies and T cells are able to counteract the
1:36.6	variance. One group of scientists found that most antibodies from convalescent plasma are aimed at the receptor binding domain on the virus spike protein.
1:47.0	Some of the variants already have ways to escape one type of antibody, but none have developed a way to evade all three classes.
1:56.0	Scientists at the National Institute of Allergy and Infectious Diseases reported this week that
2:01.8	convalescent T cells, an important part of the immune system,
2:06.0	respond appropriately to variants such as B-117,
2:10.0	originally identified in Great Britain and B1-351
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Joe and Terry Graedon, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Joe and Terry Graedon and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.